Clinical Trial

Choline Dose Ranging in Postmenopausal Women

Completed
View on ClinicalTrials.gov →
Summary
This study will use a randomized placebo-controlled trial to examine smaller doses of choline and whether a signal in the brain is detectable using fMRI. This study will examine if an even smaller doses of choline can show these similar brain activation and connectivity patterns to the 1650 mg dose. This will be a dose ranging study of 550 mg and 1100 mg oral choline compared to placebo.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-04; most recent amendment 2026-04-27.
Status change: Recruiting → Completed 2026-04-27
Trial Details
NCT Number NCT06924541
Lead Sponsor Julie Dumas
Conditions Menopause
Enrollment 20 participants
Start Date 2024-09-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04